ChemicalBook > CAS DataBase List > Dabigatran Etexilate Mesylate

Dabigatran Etexilate Mesylate

Product Name
Dabigatran Etexilate Mesylate
CAS No.
872728-81-9
Chemical Name
Dabigatran Etexilate Mesylate
Synonyms
Pradaxa;Pradaxa Mesylate;Dabigatran mesylate;Dabigatran Etexilate Mesylate API;Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-;Hexyl 2-(4-(((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbaMoyl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)Methyl)aMino)benzylidene)hydrazinecarboxylate Methanesulfonate;ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate;(E)-hexyl 2-(4-((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbaMoyl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)MethylaMino)benzylidene)hydrazinecarboxylate Methanesulfonate;N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat;Dabig
CBNumber
CB92500679
Molecular Formula
C35H45N7O8S
Formula Weight
723.85
MOL File
872728-81-9.mol
More
Less

Dabigatran Etexilate Mesylate Property

Melting point:
>125°C
storage temp. 
Refrigerator
solubility 
DMSO (Slightly, Heated), Methanol (Slightly)
form 
Solid
color 
White to Pale Yellow
InChIKey
XETBXHPXHHOLOE-UHFFFAOYSA-N
SMILES
S(O)(=O)(=O)C.CN1C(=NC2C=C(C(=O)N(C3N=CC=CC=3)CCC(=O)OCC)C=CC1=2)CNC1C=CC(C(=N)NC(=O)OCCCCCC)=CC=1
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H413May cause long lasting harmful effects to aquatic life

More
Less

N-Bromosuccinimide Price

TCI Chemical
Product number
D6198
Product name
Dabigatran Etexilate Mesylate
Packaging
1G
Price
$132
Updated
2025/07/31
Usbiological
Product number
007470
Product name
Dabigatran Etexilate Mesylate
Packaging
10mg
Price
$425
Updated
2021/12/16
Biosynth Carbosynth
Product number
FD20773
Product name
Dabigatran etexilate mesylate
Packaging
100mg
Price
$65
Updated
2021/12/16
ApexBio Technology
Product number
A3345
Product name
Dabigatranetexilatemesylate
Packaging
5mg
Price
$68
Updated
2021/12/16
ApexBio Technology
Product number
A3345
Product name
Dabigatranetexilatemesylate
Packaging
10mg
Price
$100
Updated
2021/12/16
More
Less

Dabigatran Etexilate Mesylate Chemical Properties,Usage,Production

Description

Dabigatran etexilate mesylate is a clinical direct thrombin inhibitor and a new type of oral anticoagulant. It can inhibit the formation of thrombus by reversibly and potently competing with the fibrin-specific binding site of thrombin to block fibrin generation.

Chemical Properties

Off-White to Pale Yellow Solid

History

Dabigatran Etexilate Mesylate (brand name pradaxa) was discovered from a panel of chemicals with similar structure to benzamidine-based thrombin inhibitor α-NAPAP (N-alpha-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide). Addition of ethyl ester and hexyloxycarbonyl carbamide hydrophobic side chains led to the orally absorbed prodrug, BIBR 1048 (dabigatran etexilate).
In March 2008, the European Medicines Agency (EMA) granted marketing authorization for Pradaxa for the prevention of thromboembolic disease following hip or knee replacement surgery and for non-valvular atrial fibrillation.
The National Health Service (NHS) in Britain authorized dabigatran for use in preventing blood clots in hip and knee replacement surgery patients.
Pradaxa received a Notice of Compliance (NOC) from Health Canada in June 2008,[45] for the prevention of blood clots in patients who have undergone total hip or total knee replacement surgery. Approval for atrial fibrillation patients at risk of stroke came in October 2010.
The U.S. Food and Drug Administration (FDA) approved Pradaxa in October 2010, for prevention of stroke in patients with non-valvular atrial fibrillation.
In February 2011, the American College of Cardiology Foundation and the American Heart Association added dabigatran to their guidelines for management of non-valvular atrial fibrillation with a class I recommendation.

Uses

Nonpeptide, direct thrombin inhibitor. Antithrombotic.

Clinical Use

Dabigatran Etexilate Mesylate is a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Definition

ChEBI: A methanesulfonate salt obtained by reaction of dabigatran etexilate with one equivalent of dabigatran etexilate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism.

brand name

Pradaxa

Biological Activity

Dabigatran etexilate mesylate (BIBR 1048MS) is an orally active prodrug of Dabigatran. Dabigatran etexilate mesylate has anticoagulant properties and can prevent venous thromboembolism and stroke due to atrial fibrillation.

Mechanism of action

Dabigatran etexilate mesylate is a prodrug of dabigatran that is metabolized in the body and converted to the active dabigatran. Compared with warfarin, dabigatran etexilate mesylate does not require frequent monitoring of coagulation function and dose adjustment during treatment, and there are fewer interactions between drugs and is not affected by eating, thus improving patients' medication compliance.

Side effects

The most common adverse reactions to Dabigatran Etexilate Mesylate (150 mg) were bleeding and gastrointestinal events (i.e. dyspepsia, nausea, epigastric pain, gastrointestinal bleeding, and diarrhoea). Very few patients experienced drug hypersensitivity (including urticaria, rash and pruritus), anaphylactic oedema, anaphylactic reactions and anaphylaxis.

Synthesis

211915-06-9

75-75-2

872728-81-9

Using ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate (52.6 kg, recommended to be pre-purified by recrystallization from ethyl acetate) and methanesulfonic acid as the raw material, the following steps were carried out: 1. add pre-purified ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propionate to an inerted stirring apparatus. 2. 293 kg of acetone is added, stirred and heated to 40 °C to 46 °C until a clarified solution is formed. 3. the solution was filtered through a lens filter into a second stirring device and subsequently cooled to 30°C to 36°C. 4. in another vessel, 33 kg of acetone was pre-cooled to 0 °C to 5 °C, 7.9 kg of 99.5% methanesulfonic acid and 9 kg of acetone were added and mixed well. 5. The methanesulfonic acid solution was added stoichiometrically over 15 to 40 minutes to a solution of ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propionate in a second apparatus, maintained at a temperature of 26° C. to 36° C. The ethyl 3-(2-(((4-(N-(hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benz[d]imidazole-5-carboxamide)propionate solution was added in a second apparatus, maintained at a temperature of 26° C. to 36° C. 6. After addition, stirring was continued at 26°C to 33°C for 40 to 60 minutes. 7. the mixture was cooled to 17°C to 23°C and stirred for an additional 40 to 80 minutes. 8. The crystal suspension was filtered and washed with a total of 270 L of acetone. 9. The product was dried under vacuum at not more than 50 °C for at least 4 hours. Yield: 54.5-59.4 kg, based on a theoretical yield of 90%-98% for ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate.

in vivo

Dabigatran etexilate mesylate (BIBR 1048MS; oral; 10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys) has dose- and time-dependent anticoagulant effects and has maximum effects between 30 and 120 min after administration, respectively.Dabigatran etexilate mesylate maximally and significantly prolongs partial thromboplastin time (aPTT) to 25.2, 38.4 and 78.3 s in 30 min after 10, 20 and 50 mg/kg oral doses, respectively.Dabigatran etexilate mesylate maximally prolongs the aPTT to 34.3 s, 44.0 s, and 63.0 s, respectively, 2h after 1, 2.5 or 5 mg/kg doses in the monkey.

References

[1] Patent: WO2012/44595, 2012, A1. Location in patent: Page/Page column 15
[2] Patent: WO2014/192030, 2014, A2. Location in patent: Page/Page column 26

Dabigatran Etexilate Mesylate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Dabigatran Etexilate Mesylate Suppliers

Canada 2 China 423 Germany 1 India 56 Israel 1 Poland 1 Singapore 1 Spain 1 United Kingdom 3 United States 20 Global 509
CLEANCHEM LABORATORIES LLP
Tel
--
Fax
--
Email
sales4@cleanchemlab.com
Country
India
ProdList
325
Advantage
58
Jigs Chemical Limited
Tel
--
Fax
--
Email
info@jigschemical.com
Country
India
ProdList
235
Advantage
58
ACEBRIGHT (INDIA) PHARMA PRIVATE LIMITED
Tel
--
Fax
--
Email
marketing@acebright.in
Country
India
ProdList
5
Advantage
58
Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
Triveni Interchem Private Limited (Group Of Triveni...
Tel
--
Fax
--
Country
India
ProdList
497
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58
SynZeal Research Pvt Ltd
Tel
--
Fax
--
Email
standards@synzeal.com
Country
India
ProdList
6514
Advantage
58
A.J Chemicals
Tel
--
Fax
--
Email
sales@ajchem.in
Country
India
ProdList
6100
Advantage
58
AUROBINDO PHARMA LTD
Tel
--
Fax
--
Email
info@aurobindo.com
Country
India
ProdList
209
Advantage
58
LUPIN LTD
Tel
--
Fax
--
Email
info@lupin.com
Country
India
ProdList
191
Advantage
58
BIOCON LTD
Tel
--
Fax
--
Email
info@biocon.com
Country
India
ProdList
39
Advantage
58
PIRAMAL ENTERPRISES LTD
Tel
--
Fax
--
Email
corporate.communication@piramal.com
Country
India
ProdList
45
Advantage
58
GLENMARK LIFE SCIENCES LTD
Tel
--
Fax
--
Email
api.web@glenmarklifesciences.com
Country
India
ProdList
103
Advantage
58
HETERO DRUGS LTD
Tel
--
Fax
--
Email
sales@heterodrugs.com
Country
India
ProdList
98
Advantage
58
ALEMBIC PHARMACEUTICALS LTD
Tel
--
Fax
--
Email
alembic@alembic.co.in
Country
India
ProdList
108
Advantage
58
SRINI PHARMACEUTICALS PRIVATE LTD
Tel
--
Fax
--
Email
info@srinipharma.com
Country
India
ProdList
36
Advantage
58
JUBILANT GENERICS LTD
Tel
--
Fax
--
Email
amit.chaurasia@jubl.com
Country
India
ProdList
91
Advantage
58
SOLARA ACTIVE PHARMA SCIENCES LTD
Tel
--
Fax
--
Email
info@solara.co.in
Country
India
ProdList
89
Advantage
58
SUN PHARMACEUTICAL INDUSTRIES LTD
Tel
--
Fax
--
Email
secretarial@sunpharma.com
Country
India
ProdList
175
Advantage
58
NEULAND LABORATORIES LTD
Tel
--
Fax
--
Country
India
ProdList
55
Advantage
58
OPTIMUS DRUGS PRIVATE LTD
Tel
--
Fax
--
Email
info@optimuspharma.com
Country
India
ProdList
29
Advantage
58
CADILA HEALTHCARE LTD
Tel
--
Fax
--
Email
dhavalsoni@zyduscadila.com
Country
India
ProdList
110
Advantage
58
DR REDDYS LABORATORIES LTD
Tel
--
Fax
--
Email
krishnaraoy@drreddys.com
Country
India
ProdList
201
Advantage
58
More
Less

View Lastest Price from Dabigatran Etexilate Mesylate manufacturers

WUHAN FORTUNA CHEMICAL CO., LTD
Product
Dabigatran Etexilate Mesylate 872728-81-9
Price
US $0.00/Kg/Bag
Min. Order
100g
Purity
98.5%min
Supply Ability
10KGS
Release date
2021-07-07
Hebei Longbang Technology Co., Ltd
Product
Dabigatran Etexilate Mesylate 872728-81-9
Price
US $6.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
20TONS
Release date
2024-06-04
Hebei Yanxi Chemical Co., Ltd.
Product
Dabigatran Etexilate Mesylate 872728-81-9
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100tons
Release date
2023-08-16

872728-81-9, Dabigatran Etexilate MesylateRelated Search:

5-(2-Bromoethyl)-2,3-dihydrobenzofuran 3-(S)-(+)-(1-Carbamoyl-1,1-diphenylmethyl)pyrroloidine-L-(+)-tartarate Dabigatran Etexilate iMpurity 4 Dabigatran Etexilate iMpurity 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester N-(4-CYANO-PHENYL)-GLYCINE Chloroacetic anhydride 4-Aminobenzamidine dihydrochloride 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER HEXYL CHLOROFORMATE N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride Dabigatran Etexilate iMpurity D Dabigatran iMpurity E Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate (Dabigatran IMpurity) Dabigatran iMpurity F Dabigatran etexilate Dabigatran

  • Dabigatran etexilate mesylate
  • (Z)-ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate
  • Ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-
  • Dabigatran etexilate mesylate,Pradaxa
  • ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate methanesulfonate
  • Dabigatran Mesylate Reference
  • Dabigatran mesylate
  • N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat supplier in Chin
  • CS-900
  • 3-([2-[[(4-(N-n-hexyloxycarbonylcarbamimidoyl)-phenylamino)-methyl]]-1-methyl-1H-benzimidazole-5-carbonyl]-pyridin-2-yl-amino)ethyl propionate mesylate
  • PRADAXA; BIBR 1048MS; DABIGATRAN ETEXILATE METHANESULFONATE
  • N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat
  • Pradaxa
  • Dabigatran etexilate Mesylate 872728-81-9
  • [[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanineethylesterMonoMethanesulfonat
  • Hexyl 2-(4-(((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbaMoyl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)Methyl)aMino)benzylidene)hydrazinecarboxylate Methanesulfonate
  • (E)-hexyl 2-(4-((5-((3-ethoxy-3-oxopropyl)(pyridin-2-yl)carbaMoyl)-1-Methyl-1H-benzo[d]iMidazol-2-yl)MethylaMino)benzylidene)hydrazinecarboxylate Methanesulfonate
  • N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-y
  • BIBR 1048MS
  • N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester Methanesulfonate
  • Dabigatran etexilate Methanesulfonate
  • Pradaxa Mesylate
  • ate MesyL
  • atran EtexiL
  • Dabig
  • Dabigatran EtexiL
  • Dabigatran Etexilate Mesylate USP/EP/BP
  • Dabigatran Etexilate Mesylate Pellet
  • Dabigatran Etexilate Mesylate- IH
  • B-Alanine, N-[[2-[[[4-[[[(hexyloxy) carbonyl] amino] iminomethyl] phenyl] amino] methyl]-1-methyl-1H-benzimidazol-5-yl] carbonyl]-N-2-pyridinyl -,ethyl ester, methanesulfonate
  • N-[[2-[[[4-[[[(Hexyloxy)carbonyl] amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine ethyl ester methanesulfonate
  • Dabigatran Etexilate MesylateQ: What is Dabigatran Etexilate Mesylate Q: What is the CAS Number of Dabigatran Etexilate Mesylate Q: What is the storage condition of Dabigatran Etexilate Mesylate Q: What are the applications of Dabigatran Etexilate Mesylate
  • Dabigatran Etexilate Mesylate API
  • Dabigatran etexilatemesi
  • Pradaxa, Dabigatran etexilate mesylate
  • DabigatranEtexilate Mesylate/Pellets
  • Dabigatran Etexilate Mesylate, 10 mM in DMSO
  • DABIGATRAN ETEXILATE MESYLATE [DRUG SUBSTANCE (NON-STERILE)]
  • Dabigatran Etexilate Mesylate: N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino] iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-?-Alanine- ethyl ester methanesulfonate
  • 872728-81-9
  • C34H41N7O5CH4O3S
  • C35H45N7O8S
  • Aromatics
  • Bases & Related Reagents
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Nucleotides
  • Pharmaceuticals
  • Dabigatran etexilate mesylate
  • API
  • 872728-81-9